Minocycline treatment reduces white matter damage after excitotoxic striatal injury

Brain Res. 2010 May 6:1329:182-93. doi: 10.1016/j.brainres.2010.03.007. Epub 2010 Mar 11.

Abstract

We investigated the protective effects of minocycline following white matter damage (WMD) in the rat striatum. Excitotoxic lesions were induced by N-Methyl-d-Aspartate (NMDA) microinjections and caused striatal damage, concomitant with microglial/macrophage activation. The excitotoxic lesion both damaged oligodendrocytes (Tau-1(+) cells) and caused a decrease in tissue reactivity for myelin basic protein (MBP) after post-lesional day 3 (PLD). Treatment with the semi-synthetic tetracycline antibiotic minocycline, however, led to oligodendrocyte preservation and decreased myelin impairment. Taken together, these results suggest that white matter damage (WMD) is an important component of the physiopathology of acute striatal damage and that microglial/macrophage activation contributes to this pathological phenomenon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology*
  • Antibodies, Monoclonal / metabolism
  • Brain / drug effects*
  • Brain / immunology
  • Corpus Striatum / drug effects*
  • Corpus Striatum / pathology
  • Disease Models, Animal
  • Macrophage Activation / drug effects
  • Macrophage Activation / immunology
  • Male
  • Microglia / drug effects
  • Microglia / immunology
  • Microinjections
  • Minocycline / administration & dosage
  • Minocycline / pharmacology*
  • Myelin Basic Protein / metabolism
  • N-Methylaspartate
  • Oligodendroglia / drug effects*
  • Oligodendroglia / metabolism
  • Rats
  • Rats, Wistar
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Myelin Basic Protein
  • tau-1 monoclonal antibody
  • N-Methylaspartate
  • Minocycline